0000891293-15-000029.txt : 20150729 0000891293-15-000029.hdr.sgml : 20150729 20150729180355 ACCESSION NUMBER: 0000891293-15-000029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150727 FILED AS OF DATE: 20150729 DATE AS OF CHANGE: 20150729 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CTI BIOPHARMA CORP CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2062827100 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: CELL THERAPEUTICS INC DATE OF NAME CHANGE: 19960321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SEELEY BRUCE J. CENTRAL INDEX KEY: 0001474462 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12465 FILM NUMBER: 151013881 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE CITY: BOTHELL STATE: WA ZIP: 98021 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2015-07-27 0 0000891293 CTI BIOPHARMA CORP ctic 0001474462 SEELEY BRUCE J. 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 0 1 0 0 EVP, Chief Commercial Officer Common Stock 2015-07-27 4 A 0 300000 0 A 300000 D Performance Rights 0 2015-07-27 4 A 0 406483 0 A 2016-12-31 Common Stock 406483 406483 D Restricted stock award will vest in three installments with one-third of the award on each of (i) July 27, 2016; (ii) July 27, 2017; and (iii) July 27, 2018, subject to the officer's continued service with the Company. This transaction represents a grant of performance-based restricted stock units pursuant to CTIC's long-term incentive program. The reporting person has been granted an award that is payable in shares of CTIC common stock upon the achievement of certain performance goals on or before December 31, 2016. Should such a goal be timely achieved, the number of shares payable will be determined by multiplying the payout percentage that has been assigned by CTIC to that goal multiplied by the number of shares of CTIC common stock issued and outstanding at the time that particular goal has been achieved. One such performance goal is the attainment by CTIC of a specified level of market capitalization. The units reported above reflect the 0.225% payout percentage that has been assigned by CTIC to this market capitalization goal for purposes of the reporting person's award multiplied by the number of shares of CTIC common stock issued and outstanding as of July 27, 2015. By: Louis A. Bianco, Attorney-in-fact For: Bruce J. Seeley 2015-07-29